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Abstract
A-kinase anchoring proteins (AKAPs) transmit signals cues from seven-transmembrane
receptors to specific sub-cellular locations. Mitochondrial AKAPs encoded by the Akap1
gene have been shown to modulate mitochondrial function and reactive oxygen species
(ROS) production in the heart. Under conditions of hypoxia, mitochondrial AKAP121 under-
goes proteolytic degradation mediated, at least in part, by the E3 ubiquitin ligase Seven In-
Absentia Homolog 2 (Siah2). In the present study we hypothesized that Akap1might be cru-
cial to preserve mitochondrial function and structure, and cardiac responses to myocardial
ischemia. To test this, eight-week-old Akap1 knockout mice (Akap1-/-), Siah2 knockout mice
(Siah2-/-) or their wild-type (wt) littermates underwent myocardial infarction (MI) by perma-
nent left coronary artery ligation. Age and gender matched mice of either genotype under-
went a left thoracotomy without coronary ligation and were used as controls (sham). Twenty-
four hours after coronary ligation, Akap1-/- mice displayed larger infarct size compared to
Siah2-/- orwtmice. One week after MI, cardiac function and survival were also significantly
reduced in Akap1-/- mice, while cardiac fibrosis was significantly increased. Akap1 deletion
was associated with remarkable mitochondrial structural abnormalities at electron micros-
copy, increased ROS production and reducedmitochondrial function after MI. These alter-
ations were associated with enhanced cardiac mitophagy and apoptosis. Autophagy
inhibition by 3-methyladenine significantly reduced apoptosis and ameliorated cardiac dys-
function following MI in Akap1-/- mice. These results demonstrate that Akap1 deficiency pro-
motes cardiac mitochondrial aberrations and mitophagy, enhancing infarct size, pathological
PLOS ONE | DOI:10.1371/journal.pone.0154076 May 2, 2016 1 / 16
a11111
OPEN ACCESS
Citation: Schiattarella GG, Cattaneo F, Pironti G,
Magliulo F, Carotenuto G, Pirozzi M, et al. (2016)
Akap1 Deficiency Promotes Mitochondrial
Aberrations and Exacerbates Cardiac Injury
Following Permanent Coronary Ligation via
Enhanced Mitophagy and Apoptosis. PLoS ONE 11
(5): e0154076. doi:10.1371/journal.pone.0154076
Editor: Sathyamangla Venakata Naga Prasad,
Cleveland Clinic, UNITED STATES
Received: December 17, 2015
Accepted: April 8, 2016
Published: May 2, 2016
Copyright: © 2016 Schiattarella et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported, in part, by grants
from the Ministry of Health, Italy - Young Researcher
Grant (www.ministerosalute.it - GR-2009-1596220)
and from the Ministry of University and Research,
Italy (www.miur.it - RBFR124FEN) to CP and by
Associazione Italiana per la Ricerca sul Cancro Grant
to AF (www.airc.it - IG15264).
cardiac remodeling and mortality under ischemic conditions. Thus, mitochondrial AKAPs
might represent important players in the development of post-ischemic cardiac remodeling
and novel therapeutic targets.
Introduction
Mitochondria are central to several cellular processes, as they are both the main source of
energy and reactive oxygen species (ROS), and critical regulators of cell death or survival path-
ways [1]. Mitochondrial dysfunction has been observed in a variety of cardiac diseases, includ-
ing coronary artery disease, left ventricular hypertrophy and heart failure [1–4]. During
cardiac ischemia, mitochondrial ROS production represents one of the major determinants of
infarct size and heart remodeling [4].
Recent studies have demonstrated the important role of a family of A Kinase Anchor Pro-
teins (AKAPs) in the transmission of intracellular cyclic adenosine monophosphate (cAMP)
signals to the outer membrane of mitochondria [3, 5]. Mitochondrial AKAPs (mitoAKAPs)
are products of a single gene (Akap1), and are generated by alternative RNA splicing. All splice
variants share the first 30 NH2-terminal residues mediating the targeting to the outer mito-
chondrial membrane and other functions, but diverge significantly at the C-terminus. Mito-
chondrial AKAP121 is transcriptionally regulated by cyclic adenosine monophosphate
(cAMP) in vitro and in vivo [3]. Down-regulation of AKAP121 induced by cardiac pressure
overload is associated with marked abnormalities in mitochondrial structure and function, and
increased ROS generation [3]. In addition, AKAP121 undergoes a rapid post-translational deg-
radation under hypoxic conditions mediated by the E3 ubiquitin ligase Seven In-Absentia
Homolog 2 (Siah2) [6]. Siah2 also regulates the availability of hypoxia inducible factor-1α
(HIF1-α) and other proteins [6–8], and its deletion prevents ischemia-induced cardiomyocyte
cell death and reduces infarct size after coronary artery ligation [8]. These effects might be
related, at least in part, to the regulation of AKAP121 availability and, in turn, of mitochondrial
dynamics [8].
Stress-induced mitochondrial damage increases ROS production and can cause further
damage to nearby mitochondria, the release of pro-apoptotic proteins and the amplification of
cellular damage [9]. To prevent further injury, cells can induce the activation of quality control
systems to remove damaged mitochondria by macro-autophagy or mitophagy [10, 11]. Selec-
tive degradation of damaged mitochondria may play an essential role in a number of cardiac
pathologies associated with mitochondrial dysfunction [12–15]. Although it is now recognized
the crucial role of autophagy in cardiovascular diseases, activation of autophagy mechanisms
in cardiomyocytes might be beneficial or maladaptive depending on the timing and magnitude
of the activation [16]. Whether mitoAKAPs might play a role in cardiac mitophagy is currently
unknown. In the present study, we hypothesized that Akap1 deletion might affect mitochon-
drial structure and function in the heart, and that mitoAKAPs levels might play a crucial role




All experiments involving animals were performed in conformity with the Guide for the
Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH
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Publication 8th edition, update 2011), and were approved by the animal welfare regulation of
University Federico II, Naples, Italy. Akap1-/- mice have been previously generated [17], and
were donated by Stanley McKnight (University of Washington, Department of Pharmacol-
ogy). Siah2-/- mice have been previously generated, and were provided by kindly provided by
David Bowtell PhD (Peter MacCallum Cancer Centre, Melbourne, Australia). Animals were
maintained under identical conditions of temperature (21 ± 1°C), humidity (60 ± 5%) and
light/dark cycle, and had free access to normal mouse chow.
Transthoracic echocardiography
Cardiac function was non-invasively monitored by transthoracic echocardiography using the
Vevo 770 high resolution imaging system using a 30-MHz RMV-707B scanning head (Visual-
Sonics, Toronto, Canada) before the surgery and right before termination, one week after sur-
gery, as previously described [18, 19].
Mouse model of myocardial infarction
Mice were anesthetized with an intraperitoneal injection of 1 ml/kg (50 mg/kg) of a mixture of
50% tiletamine and 50% zolazepam (50 mg/ml tiletamine and 50 mg/ml zolazepam, Zoletil 100),
plus xylazine 5 mg/Kg (Sigma-Aldrich) [18, 19]. The adequacy of anaesthesia was confirmed by
the absence of reflex response to foot squeeze. Myocardial infarction (MI) was induced in
Akap1-/- (n = 27), Siah2-/- (n = 27) and their wild type (wt) littermates (n = 32) by permanent
coronary artery ligation as previously described [4]. Sham-operated animals underwent the
same procedure without ligation of the left coronary artery. Two additional groups of Akap1-/-
or wtmice underwent systemic delivery by intraperitoneal injection of the autophagy inhibitor
3-methyladenine (3MA) one day before and every day after MI for one week (MI 1wk + 3MA,
40 mg/kg IP, n = 8 for both genotypes).
To determine infarct size, 24 hours after coronary artery ligation mice of both genotypes
were anesthetized, the hearts were perfused with 1% Evans blue to determine the area at risk,
and then removed. Each heart was sliced horizontally to yield four slices, and the slices were
incubated in 1% triphenyltetrazolium chloride (TTC; Sigma-Aldrich) prepared with 200
mmol/L Tris buffer (pH 7.8) for 15 min at 37°C. With this procedure, viable non-ischemic
myocardium stains blue, ischemic but still viable myocardium stains red, whereas the necrotic
myocardium does not stain and appears pale white. The infarct area (IA, white), the area at risk
(AAR, red and white) and the total left ventricle area (LV) were measured in each section using
an image analyzer (Image J Software). IA/LV, AAR/LV and IA/AAR ratios were calculated and
expressed as a percentage. In additional groups of mice, the hearts were harvested one hour,
four hours and one week after coronary artery ligation and flash-frozen in liquid nitrogen to
perform molecular analyses or fixed in specific fixatives to perform histological analyses (see
below).
Electron microscopy
Cardiac samples from animals of the different groups (n = 3/group) were fixed with 1% Glu-
taraldehyde (8% Aqueous Solution, Electron Microscopy Sciences) in Sodium Cacodylate
buffer 0.2 M pH 7.4. The specimens were washed in distilled water, stained with 2% Osmium
tetroxide and 0.5% Uranyl acetate, dehydrated through a graded series of ethanol ethanol (50,
70, 90, and 100%), Propylene Oxide and embedded in Epon resin (Sigma) and polymerized at
60°C for 72 h. Ultrathin (60 nm) sections were cut with a Leica EM UC7 ultramicrotome
(Leica Microsystems GmbH, Wetzlar, Germany) and mounted on grids. Images were acquired
from thin sections using a FEI Tecnai 12 transmission electron microscope (FEI Company,
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Hillsboro, Oregon, USA) equipped with a Veleta CCD digital camera (Olympus Soft Imaging
Solutions GmbH, Münster, Germany). Count and quantification of mitochondria was per-
formed using the iTEM software (Soft Imaging Systems GmbH, Münster, Germany). For
quantification, 15 random regions for each sample were considered.
Cardiac histology
Mouse heart specimens were fixed in 4% formaldehyde and embedded in paraffin. After de-
paraffinization and re-hydratation, 4 μm-thick sections were prepared, mounted on glass slides
and stained with Sirius Red as previously described [4]. To quantify myocardial capillary den-
sity, lectin staining was used to specifically stain endothelial cells, as previously described [20].
TUNEL staining
The DNA nicks were determined with the use of an in situ Apoptosis Detection kit or ApopTag
Fluorescein Direct in Situ Apoptosis Detection kit (Chemicon) according to manufacturer’s
instructions as previously described [4, 21]. TUNEL staining was visualized by specific green
fluorescence and nuclei by 4'-6-diamidino-2-phenylindole (DAPI). The number of TUNEL-
positive cardiomyocytes nuclei was counted, and data were normalized per total nuclei identi-
fied by DAPI staining in the same sections (n = 7–8 animals/group). Equal numbers of cells
were analyzed per group, and statistical analysis was performed on myocyte groups by 2-way
ANOVA.
Protein extraction andWestern Blotting
Left ventricular samples were homogenized in a buffer containing 50 mM Tris–HCl (pH 7.4),
150 mM NaCl, 1% Nonidet P40, 1 mM EDTA, 0.25% sodium deoxycholate, 10 mMNaF,
10 μMNa3VO4, 1 mM phenylmethylsulfonylfuoride, and a protease inhibitor cocktail (10 g/ml
aprotinin, 10 g/ml pepstatin, 10 g/ml leupeptin) [22] using the program Protein_1 on a Gentle-
MACS tissue Dissociator (Miltenyi Biotec). Lysates were centrifuged at 14,000 rpm for 15 min
and protein concentrations in all lysates were measured using a dye-binding protein assay kit
(Bio-Rad) and a spectrophotometer reader (Biorad) at a wavelength of 595 nm. Immunoblot-
ting was performed using commercially available antibodies anti-PARP-1 (mouse monoclonal,
Santa Cruz), p62 (rabbit polyclonal, Cell Signaling) and α-Tubulin (mouse monoclonal, Santa
Cruz). Secondary antibodies were purchased from Amersham Life Sciences Inc. Bands were
visualized by enhanced chemiluminescence (ECL; Amersham Life Sciences Inc.) according to
the manufacturer’s instructions, and were quantified using densitometry (Chemidoc, Biorad,
USA). All experiments and densitometric quantifications were separately repeated at least
three times.
Mitochondrial ROS generation and aconitase activity
Mitosox Red (Molecular Probes) was used to assess the generation of mitochondrial superoxide
in vivo as previously described [4]. Changes in mitochondrial aconitase activity were also eval-
uated as previously described [4].
Mitochondria isolation and detection of respiratory parameters
Mitochondrial respiration rate was detected on isolated mitochondria from Akap1-/- (n = 4),
Akap1+/- (n = 4) or wt (n = 4) hearts as previously described [4]. Heart tissue fragments were
gently homogenized in 10 vol of an isolation medium consisting of 220 mMmannitol, 70 mM
sucrose, 20 mM TrisHCl, 1 mM EDTA, and 5 mM EGTA (pH 7.4). Then, 0.1 mg protease/g
Akap1, Mitochondria and Myocardial Ischemia
PLOS ONE | DOI:10.1371/journal.pone.0154076 May 2, 2016 4 / 16
tissue (nagarse 12 U/mg protein) was added to the homogenate and incubated for 4 min at
4°C, The homogenate was then centrifuged at 8,000 g for 10 min at 4°C. The pellet was resus-
pended in 10 vol of isolation medium (supplemented with 0.5% fatty acid free BSA), subjected
to very gentle homogenization, and centrifuged 500 g for 10 min at 4°C. The resulting superna-
tant was centrifuged at 8,000 g, in order to obtain the mitochondrial pellet, that was washed
twice, re-suspended in a minimal volume, and kept on ice until further determinations.
Mitochondrial respiration was measured polarographically by using a Clark type oxygen
electrode (Rank Brothers) at 37°C in 0.5 mL of respiratory buffer (KCl 80 mmol/L, HEPES 50
mmol/L, EGTA 1 mmol/L, KH2PO4 5 mmol/L, MgCl2 2 mmol/L, 0.5% BSA, pH 7.0). After
recording basal respiration, state 2 respiration was initiated by adding glutamate 5 mmol/L and
malate 2.5 mmol/L as substrates for complex I or succinate 5 mmol/L (in combination with
rotenone 2 μmol/L to inhibit complex I) as substrate for complex II. Complex IV respiration
was determined after the addition of antimycin A (1.8 μmol/L) to the respiratory buffer in
order to inhibit complex II and TMPD (N,N,N',N'-tetramethyl-p-phenylenediamine) 300 μmol/
L and ascorbate 3 mmol/L, which donates electrons to cytochrome oxidase via the reduction of
cytochrome c. State 3 respiration was determined after the addition of 300 μmol/L ADP.
Statistical analysis
All data presented are expressed as mean ± SE and are representative of three or more indepen-
dent experiments. Comparisons between 2 groups were performed using the unpaired Student
t test. For MI experiments, comparisons were made by 2-way analysis of variance (ANOVA)
or, when noted, by 1-way ANOVA, and p values shown indicate the effect of genotype on the
MI-stimulated response. Correction for multiple comparisons was made using the Student–
Newman–Keuls method. A minimum value of p<0.05 was considered statistically significant.
Kaplan-Meier survival analysis was performed using GraphPad Prism version 6.01 (GraphPad
Software, Inc. La Jolla, CA), and differences were considered to be statistically significant at a
value of P<0.05 by log-rank test.
Results
Akap1 deletion enhances infarct size and exaggerates adverse cardiac
remodeling and mortality after permanent coronary artery ligation
To investigate the functional role of mitoAKAPs in the heart, we studied mice with global
genetic deletion of the Akap1 gene (Akap1-/-) and their wt littermates. Akap1-/- mice appear
normal and healthy, even if their body weight is lower compared to their wt littermates
(Table 1). Under basal conditions or after the sham operation, cardiac morphometry and func-
tion of Akap1-/- or Akap1+/- mice was not significantly different from wtmice (Table 1). To test
whether Akap1 deletion might influence mitochondrial respiratory pathways, we determined
respiration rates by using three different substrates, such as piruvate+malate, succinate+rote-
none, TmPD+ ascorbate + antimycine in Akap1-/-, Akap1+/- and wtmice. These substrates
allowed us to evaluate the activity of complex I, complex II and complex IV-linked respiratory
pathways, respectively. Mitochondrial respiration rates were not statistically different between
the groups (S1 Fig), whatever the substrate considered, thus indicating that Akap1 deletion,
partial or total, does not influence cardiac mitochondrial functionality under basal conditions.
To test the role of mitoAKAPs under conditions of myocardial ischemia, myocardial infarc-
tion (MI) was induced by permanent coronary artery ligation in wt, Akap1-/- and Siah2-/- mice.
Sham-operated animals from all genotypes underwent the same surgical procedure without
occlusion of the coronary artery (Table 1). Four hours after MI, wtmice displayed a significant
Akap1, Mitochondria and Myocardial Ischemia
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reduction in cardiac AKAP121 levels (Fig 1A) that persisted up to four weeks after MI (data
not shown). As expected, AKAP121 down-regulation was significantly inhibited in Siah2-/-
mice (Fig 1A). Twenty-four hours following permanent coronary artery ligation, hearts were
infused with Evans blue to demarcate the ischemic area susceptible to infarction (area at risk,
AAR), and counterstained with triphenyltetrazolium chloride (TTC) to identify the final
infarct area (IA) from the viable myocardium within the AAR. Compared to wt, Akap1-/-
hearts demonstrated a significantly larger proportion of infarcted myocardium within the LV
and the AAR, and the AAR displayed a not statistically significant increasing trend (Table 2).
In contrast, consistent with previous results [8], the IA/AAR ratio was significantly lower in
Siah2-/- mice (Fig 1B and Table 2).
Since infarct size is one of the major determinants of adverse post-ischemic remodeling, car-
diac function was evaluated by trans-thoracic echocardiography in wt, Akap1-/- and Siah2-/-
mice one week after MI. In contrast to Siah2-/-mice, Akap1-/- mice displayed a significant wors-
ening in cardiac function after coronary artery ligation (Fig 1C), and a more pronounced
increase in left ventricular weight (LVW) to body weight (BW) ratio at study termination com-
pared to wtMI mice (Fig 1D and Table 1).
To assess whether these differences would translate into a survival benefit, survival rates
were monitored for seven days in all the groups after the surgery. As expected, survival of sham
mice was 100%, while MI resulted in a lower survival in all genotypes compared to the respec-
tive sham group. Interestingly, the 7-day-survival of Akap1-/- MI mice was significantly lower
compared to wt or Siah2-/- MI mice (Fig 1E).
Increased apoptosis and fibrosis in Akap1-/- hearts after myocardial
infarction
To determine whether abnormal vascularization might be responsible for the increased infarct
size in Akap1-/- mice, histological studies were performed in the peri-infarct zone to stain
Table 1. Cardiac morphometry and echocardiography of mice from the different groups.
sham MI 1wk
wt Siah2-/- Akap1+/- Akap1-/- wt Siah2-/- Akap1-/-
(n = 8) (n = 9) (n = 7) (n = 8) (n = 8) (n = 10) (n = 7)
BW, g 27.1 ± 0.9 26.3 ± 1.0 24.3 ± 1.0 23.4 ± 1.3# 27.4 ± 1.5 26.8 ± 1.4 24.6 ± 3.3
LVW, mg 85.6 ± 2.7 83.4 ± 3.2 76.8 ± 2.5 75.9 ± 3.8 90.7 ± 8.1* 95.8 ± 6.2* 95.6 ± 7.4*
LAW, mg 4.8 ± 0.3 5.1 ± 0.5 5.9 ± 0.5 6.3 ± 0.7 7.1 ± 2.3 8.1 ± 1.6 13.3 ± 2.6*§
HW, mg 106.4 ± 2.5 103.7 ± 2.8 96.0 ± 2.5 98.3 ± 5.1 117.1 ± 6.4* 105.8 ± 7.8 131.5 ± 10.7*§
LVW/BW 3.1 ± 0.1 3.2 ± 0.2 3.2 ± 0.1 3.0 ± 0.1 3.3 ± 0.2 3.6 ± 0.2 3.9 ± 0.2*§
HW/BW 3.9 ± 0.1 3.8 ± 0.1 4.0 ± 0.1 4.1 ± 0.1 4.3 ± 0.3 4.3 ± 0.2 5.3 ± 0.2*§
LVEDd, mm 3.1 ± 0.1 3.1 ± 0.1 3.0 ± 0.1 3.0 ± 0.1 3.6 ± 0.2* 3.4 ± 0.1 3.7 ± 0.3*
LVESd, mm 1.3 ± 0.1 1.3 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 2.2 ± 0.2* 1.9 ± 0.1* 2.7 ± 0.3*§
IVSd, mm 0.8 ± 0.1 0.7 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.6 ± 0.1 0.7 ± 0.1 0.6 ± 0.1
PWd, mm 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.8 0.8 ± 0.1 0.7 ± 0.1 0.8 ± 0.1 0.7 ± 0.1
FS, % 57.7 ± 2.0 58.1 ± 1.8 60.7 ± 2.3 56.7 ± 1.8 39.1 ± 4.4* 45.1 ± 3.1* 28.3 ± 3.3*§
HR, bpm 462 ± 26 484 ± 20 546 ± 35 498 ± 10 556 ± 47 508 ± 22 513 ± 33
Abbreviations used: Body weight, BW; left ventricle weight, LVW, left atrium weight, LAW; heart weight, HW; left ventricular end-diastolic diameter,
LVEDd; left ventricular end-systolic diameter, LVESd; interventricular septum end-diastolic diameter, IVSd; posterior wall end-diastolic diameter, PWd;
fractional shortening, FS; heart rate, HR (#p<0.05 vs. correspondent wt; *p<0.05 vs. wt sham; §p<0.05 vs. wt MI).
doi:10.1371/journal.pone.0154076.t001
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Fig 1. Akap1 genetic deletion increases infarct size and reduces survival after myocardial infarction. (A)
Representative immunoblot (top) and densitometric analysis (bottom) of 4 independent experiments to evaluate
AKAP121 protein levels in heart samples from wild type (wt), Siah2-/- and Akap1-/- mice after the sham procedure
or after 4 hours of permanent coronary artery ligation (MI 4 h) (*p<0.05 vs. sham; n = 5 hearts/group). Tubulin
protein levels did not significantly change among the samples. (B) Left: Representative images of TTC staining
Akap1, Mitochondria and Myocardial Ischemia
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cardiac capillaries in all experimental groups. Although coronary anatomy was not determined,
sham Akap1-/- mice displayed a cardiac capillary density similar to wt (Fig 2A). As expected,
coronary artery ligation induced a significant reduction in myocardial capillary density in both
Akap1-/- and wtmice, and no significant differences among MI groups were observed (Fig 2A).
To assess whether enhanced apoptotic cell death might be involved in the increased infarct
size observed in Akap1-/- mice, terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) staining was performed in cardiac sections from the different groups. Compared to
MI, sham hearts from both groups displayed a significant increase in the rate of TUNEL posi-
tive nuclei in the infarct zone (Fig 2B). However, MI Akap1-/- mice displayed a significantly
increased rate of apoptotic nuclei compared to MI wt (Fig 2B). Consistent with these observa-
tions, cardiac levels of cleaved Poly (ADP-ribose) polymerase (PARP), a marker of apoptosis,
were significantly higher in MI Akap1-/- mice compared to MI wt (Fig 2C). The increased rates
of apoptotic cell death observed after MI in Akap1-/- mice were also associated to a significant
increase in interstitial fibrosis after MI compared to wt (Fig 2D). Consistent with previous in
vitro observations [23] Akap1-/- MI hearts were also characterized by enhanced cardiomyocyte
hypertrophy in the peri-infarct zone, as shown by increased cross-sectional area (S2 Fig).
Akap1 deletion induces mitochondrial aberrations and enhances cardiac
mitophagy
We have previously shown that cardiac AKAP121 downregulation under conditions of pres-
sure overload is associated with mitochondrial abnormalities [3]. To determine whether Akap1
deletion might directly affect mitochondrial structure, we next investigated mitochondrial
morphology at electron microscopy in Akap1-/- mice and their wt littermates, either after the
sham operation or one hour MI. In sham wt hearts, mitochondria displayed normal size and
shape, and were organized in rows perpendicular to the myocardial Z-lines as expected (Fig
3A, top left panel). In contrast, mitochondria in Akap1-/- sham hearts were more disorganized
around the fibers, and were characterized by significant alterations in the architecture, includ-
ing mitochondrial swelling, matrix dilution, reduced number and/or fragmentation of mito-
chondrial cristae (Fig 3A, top middle panel). One hour after coronary artery ligation, a
significant increase in the percent number of aberrant mitochondria was observed in wtMI
of heart sections fromwt, Akap1-/- or Siah2-/- mice 24 hours after MI. Right: Bar graphs showing ratios of
myocardial infarct area (IA) over area at risk (AAR) in MI mice from all the groups (*p<0.05 vs.wtMI). (C)
Cumulative data of % fractional shortening 1 week after the sham or MI procedures (MI 1 wk) inwt, Akap1-/- or
Siah2-/- mice (*p<0.05 vs. sham; §p<0.05 vs.wtMI). (D) Bar graphs showing cumulative data of left ventricular
weight (LVW) to body weight (BW) ratio 1 week after the sham or MI procedures inwt, Akap1-/- or Siah2-/-mice
(*p<0.05 vs. sham; §p<0.05 vs. wt MI). (E) Kaplan–Meier cumulative survival analysis ofwt, Akap1-/- or Siah2-/-
mice after the sham (wt: n = 8; Siah2-/-: n = 9; Akap1-/-: n = 8) or MI procedures (wt: n = 10; Siah2-/-: n = 9;
Akap1-/-: n = 11, *p<0.05 vs. sham; §p<0.05 vs.wtMI).
doi:10.1371/journal.pone.0154076.g001
Table 2. Infarct area and area at risk 24 hours after permanent coronary artery ligation in mice from the different experimental groups.
wt (n = 12) Siah2-/- (n = 9) Akap1-/- (n = 4)
IA/LV (%) 21.8 ± 7.7 (s.e. = 2.2) 16.6 ± 3.4 (s.e. = 1.1) 42.6 ± 9.1* (s.e. = 4.5)
IA/AAR (%) 64.2 ± 15.4 (s.e. = 4.4) 45.1 ± 13.5# (s.e. = 4.5) 84.9 ± 4.4* (s.e. = 2.2)
AAR/LV (%) 32.8 ± 14.1 (s.e. = 4.1) 38.3 ± 8.4 (s.e. = 2.8) 49.5 ± 9.0 (s.e. = 4.5)
Abbreviations used: infarct area, IA; area at risk, AAR; left ventricle area, LV. Data are mean ± standard deviation; standard error (s.e.) is also reported
for each group (*p<0.05 vs. wt; #p<0.05 vs. wt and Akap1-/-).
doi:10.1371/journal.pone.0154076.t002
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Fig 2. Akap1 genetic deletion enhances apoptosis and fibrosis after myocardial infarction. (A) Left:
Representative lectin staining of cardiac sections fromwt or Akap1-/- hearts after the sham procedure or 7 days of
permanent coronary artery ligation (MI 1wk). Capillaries appear brown. Right: Bar graphs of cumulative data of
multiple independent experiments analyzing capillary density in the different groups (*p<0.05 vs. sham; n = 4 hearts/
groups). (B) Left: Representative DAPI and TUNEL staining of cardiac sections fromwt or Akap1-/- mice after the
Akap1, Mitochondria and Myocardial Ischemia
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hearts (Fig 3A, bottom left panel), and these alterations were significantly higher in Akap1-/-
MI hearts (Fig 3A, bottom middle and right panels). After one hour MI, in both genotypes
there was an increase in aberrant mitochondria sequestered within double-membrane struc-
tures (mitophagosomes), and in MI Akap1-/- hearts the percent number of mitophagosomes
was significantly higher than MI wt (Fig 3B). Consistent with these results, endogenous p62
levels, a ubiquitin-binding scaffold protein that co-localizes with ubiquitinated protein aggre-
gates and is usually degraded during autophagy or mitophagy [24], were significantly reduced
in wtMI hearts after one week compared to sham, and further reduced in Akap1-/- MI hearts
compared to wtMI (Fig 3C).
Consistent with these results, despite the severe morphological mitochondrial abnormalities
in sham Akap1-/- hearts, aconitase activity was not statistically different compared to wt (Fig
3D). However, aconitase activity was significantly reduced after MI in both genotypes, and was
significantly lower in Akap1-/- MI hearts compared to wt (Fig 3D). Similarly, mitochondrial
ROS production, measured by Mitosox staining, was not statistically different among the sham
groups, while it increased after MI in both genotypes, and was significantly higher in Akap1-/-
MI hearts compared to wt (Fig 3E).
Inhibition of autophagy reduces apoptosis and ameliorates cardiac
dysfunction in Akap1-/- mice
In order to determine whether autophagy inhibition might exert beneficial effects in Akap1-/-
hearts and prevent at least some of the detrimental features induced by MI, wt and Akap1-
mice were pre-treated with the autophagy inhibitor 3-methyladenine (3MA) for three days,
and subsequently underwent the sham or MI one week procedures. As shown in Fig 4A, 3MA
efficiently prevented p62 degradation in both wt and Akap1-/- MI mice. Interestingly, 3MA
treatment reduced apoptotic cell death in Akap1-/- mice after MI (Fig 4B and 4C), and although
it increased myocardial fibrosis in the same group (Fig 4D), it significantly improved cardiac
dysfunction in Akap1-/- mice one week after MI, as shown by a significant increase in % frac-
tional shortening (Fig 4E). This beneficial effect was mainly due to a reduction in left ventricu-
lar end-systolic dimensions (LVESd) (Fig 4F), while left ventricular end-diastolic dimensions
(LVEDd) were unchanged in 3MA-treated MI mice compared to untreated animals (Fig 4E).
Discussion
This paper demonstrates, for the first time, that Akap1 is required to preserve mitochondrial
structure in the heart, since its genetic deletion results in mitochondrial morphological abnor-
malities and enhanced mitophagy. Under conditions of myocardial ischemia, Akap1 deletion
increases cardiomyocyte mitophagy and apoptosis, enhances infarct size and adverse cardiac
remodeling, ultimately reducing survival after myocardial infarction. Autophagy inhibition
reduces apoptosis and ameliorates cardiac dysfunction in a Akap1-/- mice, suggesting that
sham procedure or MI 1wk. Positive nuclei appear green. Right: Bar graphs of cumulative data of multiple
independent experiments on TUNEL staining (*p<0.05 vs. sham; §p<0.05 vs.wtMI; n = 4 hearts/group). (C)
Representative immunoblots (left) and densitometric analysis (right) of 4 independent experiments to evaluate
cleaved PARP-1 protein levels inwt and Akap1-/- mice after the sham or MI 1wk procedures. Tubulin protein levels
did not significantly change among the samples (*p<0.05 vs. sham; §p<0.05 vs. wt MI; n = 5 hearts/group). (D) Left:
Representative images of Sirius red staining of cardiac sections fromwt or Akap1-/- mice 7 days after the sham
procedure or MI (60Xmagnification). Right: Bar graphs showing cumulative data of multiple independent
experiments analyzing percent fibrosis in peri-infarct areas (*p<0.05 vs. sham; §p<0.05 vs.wtMI; n = 4 hearts/
groups).
doi:10.1371/journal.pone.0154076.g002
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Fig 3. Akap1 genetic deletion promotes mitochondrial dysfunction and enhancesmitophagy after
myocardial infarction. (A) Representative electron microscopy images of mitochondria in cardiac sections fromwt
or Akap1-/- mice after the sham procedure or one hour of permanent coronary artery ligation (MI 1h) and bar graphs
showing cumulative data of multiple independent experiments to quantify %mitochondrial aberrations (n = 3 hearts/
group; scale bars and magnifications are reported in the single panels; *p<0.05 vs.wt sham; §p<0.05 vs. wt MI). (B)
Akap1, Mitochondria and Myocardial Ischemia
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mitochondrial damage and enhanced mitophagy in this model might be responsible, at least in
part, for the development of the pathological phenotype.
Targeting of cAMP-dependent protein kinase (PKA) by mitoAKAPs plays a major role in
mitochondrial pathophysiology, generating local signal transduction units that include signal-
ing enzymes, adaptor molecules and mRNAs [7]. Under myocardial ischemia, AKAP121 levels
were reduced most likely as consequence of enhanced degradation by the hypoxia-induced E3
ligase Siah2 [6–8]. Indeed, genetic deletion of Siah2 prevented AKAP121 degradation after cor-
onary artery ligation, and this effect was associated with reduced infarct size and enhanced sur-
vival after MI in Siah2-/- mice compared to wt. These results suggest that modulation of
AKAP121 levels by Siah2 during myocardial ischemia might be crucial for cardiomyocyte sur-
vival and, in turn, for post-ischemic cardiac remodeling and survival.
By using a genetic model of Akap1 global deletion, we directly investigated the role of
mitoAKAPs in the regulation of mitochondrial structure and function in the heart under basal
conditions or after myocardial infarction [8]. Akap1-/- or Akap1+/- mice appear normal, and
even if Akap1-/- mice presented lower body weight compared to their wt littermates, under rest-
ing conditions their heart rate, LV/BW and HW/BW ratios were not significantly different
from the different genotypes. Moreover, cardiomyocyte cross-sectional area in Akap1-/- sham
hearts was similar to sham wt (S2 Fig), and cardiac mitochondrial respiration was normal
under basal conditions in both Akap1-/- or Akap1+/- mice (S1 Fig). Despite this apparently nor-
mal phenotype, Akap1-/- cardiomyocytes displayed remarkable mitochondrial morphological
aberrations, without evidence of increased apoptosis or fibrosis under basal conditions.
After permanent coronary artery ligation, Akap1-/- MI mice displayed enhanced mitophagy,
ROS production and apoptosis compared to wtMI mice. Cardiac fibrosis and cardiomyocyte
hypertrophy in the peri-infarct zone was also significantly increased in these mice compared to
MI wt. Although studies in isolated adult cardiomyocyets were not performed, it is possible to
speculate that basal mitochondrial disarray observed in Akap1-/- hearts, albeit compensated
under basal conditions, increases cardiomyocyte susceptibility to ischemia, enhancing cardio-
myocyte death, accelerating cardiac dysfunction and in turn reducing post-MI survival.
Although the role of cardiomyocytes autophagy during cardiovascular disease is well docu-
mented [25–28], less is known about mitochondrial autophagy (mitophagy) in the regulation
of cardiomyocytes survival and remodeling [2, 29, 30]. Our findings unveil the function of
Akap1 in the control of mitophagy under ischemic conditions, and suggest that mitoAKAPs
might represent another important example of mitochondrial proteins crucially involved in
cardiac adaptations to pathological stimuli [2]. In the absence of Akap1, mitochondrial abnor-
malities likely increased cardiac mitophagy and, by enhancing ROS production, enhanced car-
diomyocytes apoptosis during ischemia. Interestingly, autophagy inhibition did not exert
beneficial effects in wtmice undergoing MI, and rather increased apoptosis while not affecting
cardiac fibrosis in this group of mice. Taken together, these results suggest that a delicate (and
Left: Representative electron microscopy images of mitophagosomes observed in Akap1-/- MI 1h mice.
Magnifications and scale bars are reported in the single panels.Right: Bar graphs showing quantitative data on %
mitophagosomes observed inwt or Akap1-/- after the sham or MI 1h procedures (*p<0.05 vs. sham; §p<0.05 vs. wt
MI). (C) Representative immunoblot and densitometric analysis of 4 independent experiments to evaluate p62
protein levels inwt and Akap1-/- mice after the sham or MI 1wk procedures. Tubulin protein levels did not significantly
change among the samples (*p<0.05 vs. sham; §p<0.05 vs. wt MI; n = 6 hearts/group). (D) Bar graphs showing
cumulative data of multiple independent experiments measuring mitochondrial aconitase activity inwt or Akap1-/-
cardiac mitochondria after the sham or MI 1h procedures (*p<0.05 vs. sham; §p<0.05 vs. wt MI; n = 4 hearts/group).
(E) Bar graphs showing cumulative data of multiple independent experiments to assess mitochondrial ROS
generation inwt or Akap1-/- heart sections after the sham or MI 1h procedures (*p<0.05 vs. sham; §p<0.05 vs.wtMI
1h; n = 4 hearts/group).
doi:10.1371/journal.pone.0154076.g003
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Fig 4. Inhibition of autophagy reduces apoptosis and ameliorates cardiac dysfunction in Akap1-/- mice. (A)
Densitometric analysis of 3 independent experiments to evaluate p62 protein levels inwt and Akap1-/- mice after the
sham procedure or 1 week of permanent coronary artery ligation (MI 1 wk), either untreated (-) or treated (+) with
3-methyladenine (3MA). Tubulin protein levels did not significantly change among the samples (*p<0.05 vs. sham;
§p<0.05 vs.wtMI; n = 5 hearts/group). (B) Left: Representative DAPI and TUNEL staining of cardiac sections fromwt
Akap1, Mitochondria and Myocardial Ischemia
PLOS ONE | DOI:10.1371/journal.pone.0154076 May 2, 2016 13 / 16
complex) balance regulating mitochondrial dynamics might be required to preserve cardiac
function during hypoxia, and while inhibition of “exaggerated”mitophagy in Akap1-/- hearts is
beneficial, the same molecular intervention, under different conditions, might be neutral or
even detrimental.
Although mitochondrial alterations of morphology and function observed in Akap1-/-
hearts are likely attributable to the reduced targeting of PKA and associated complexes on the
outer mitochondrial membrane, the precise molecular signaling pathways involved in the
development of mitochondrial structural abnormalities and mitophagy are currently not
known. Several molecular partners have been previously described for mitoAKAPs, as well as
important mitochondrial PKA substrates [31, 32]. The presence of the N-terminus extra-
sequence that switches localization of AKAP149 from mitochondria to the endoplasmic reticu-
lum [33–35] suggests that targeting the scaffold complex on distinct organelles might also rep-
resent a strategic and rapid mechanism to efficiently redirect cAMP signaling to distinct
intracellular routes. Importantly, we cannot exclude that some of the features observed in
Akap1-/- mice might be dependent, at least in part, on the differential subcellular localization of
the splicing variants to the sarcoplasmic reticulum also. The extra-mitochondrial effects of
Akap1 global deletion must be taken into account and deserve future investigation.
In conclusion, our findings highlight the critical role of mitochondrial AKAPs in cardiac
responses to ischemia, modulating mitochondrial structure, ROS production and mitophagy
and ultimately infarct size, cardiac remodeling and survival after MI. Therefore, Akap1might
represents a novel important therapeutic target in ischemic cardiac diseases.
Supporting Information
S1 Fig. Mitochondrial respiratory parameters in hearts from wt, Akap1-/- and Akap1+/-mice.
Mitochondrial respiratory parameters [State 2, State 3, and respiratory control ratio (RCR)] in
hearts from wt, Akap1-/- and Akap1+/-mice. (A) Parameters were detected in presence of Com-
plex I-linked substrate (Piruvate+malate), Complex II-linked substrate (succinate+rotenone)
(B), Complex IV linked substrate (TmPD + ascorbate + antimycin) (C). Values represent
mean ± SE of 3–4 different hearts, each one performed in duplicate.
(TIF)
S2 Fig. Cardiomyocyte cross-sectional area in cardiac sections from wt or Akap1-/- mice
after the sham procedure or 1 week MI. (A) Representative microphotographs of cardiac
cross-sections from wt and Akap1-/- mice undergoing the sham procedure (sham) or 1-week
myocardial infarction (MI 1 wk) stained with wheat germ agglutinin (WGA) and counter-
stained with DAPI. Scale bar = 100 μm. (B) Quantification of cardiomyocytes area (p<0.05
vs. sham wt; §p<0.05 vs. all; n = 3–4 animals/group).
(TIF)
and Akap1-/- MI 1wk mice, untreated or treated with 3MA (20X magnification). Positive nuclei appear green.Right: Bar
graphs representation of cumulative data of multiple independent experiments (*p<0.05 vs.wtMI; §p<0.05 vs.wtMI
1wk ± 3MA; n = 4 hearts/group). (C) Representative immunoblot (left) and densitometric analysis (right) of three
independent experiments to evaluate cleaved PARP-1 protein levels inwt or Akap1-/- mice after the sham or MI 1wk
procedure, ±3MA. Tubulin protein levels did not significantly change among the samples (*§p<0.05 vs. sham; §p<0.05
vs.wtMI 1wk; #p<0.05 vs. Akap1-/- MI 1wk; n = 5 hearts/group). (D) Left: Representative images of Sirius red staining
of cardiac sections fromwt and Akap1-/- mice after MI (1wk), untreated or treated with 3MA (60Xmagnification). Right:
Bar graphs summarizing cumulative data of multiple independent experiments (*p<0.05 vs. sham; §p<0.05 vs.wtMI
1wk; #p<0.05 vs. Akap1-/- MI 1wk; n = 4 hearts/group). (E)Cumulative data of % fractional shortening (E), left
ventricular end-systolic dimensions (LVESD) (F) and left ventricular end-diastolic dimensions (LVEDD) (G) inwt or
Akap1-/- mice undergoing the sham, MI 1wk or MI 1wk + 3MA procedures (for all, *p<0.05 vs. sham; §p<0.05 vs.wtMI
1wk; #p<0.05 vs. Akap1-/- MI 1wk).
doi:10.1371/journal.pone.0154076.g004
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